• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Vertex Pharmaceuticals Inc

+ Add to Watchlist

VRTX:US

97.4800 USD 1.1700 1.21%

As of 11:00:12 ET on 07/22/2014.

Company Profile for Vertex Pharmaceuticals Inc (VRTX)

Vertex Pharmaceuticals Incorporated discovers, develops, and commercializes novel, small molecule pharmaceuticals for the treatment of diseases for which there are currently limited or no effective treatments. The Company is developing drugs for the treatment of viral diseases, multidrug resistance in cancer, inflammatory and autoimmune diseases, and neurodegenerative diseases.

Contact Information

Vertex Pharmaceuticals Inc

50 Northern Avenue
Boston, MA 02210
United States
Phone: 1-617-341-6100
Fax: 1-617-444-6680

Key Executives for Vertex Pharmaceuticals Inc (VRTX)

Jeffrey M LeidenChairman/President/CEOIan F SmithExec VP/CFO
Stuart A ArbuckleExec VP/Chief Commercial OfcrKenneth L Horton "Ken"Exec VP/Chief Legal Officer
Peter MuellerExec VP:Global Research & DevJeffrey A Chodakewitz "Jeff"Senior VP/Chief Medical Officer
Megan E PaceSenior VP:Corp CommunicationsChristiana StamoulisSenior VP:Corporate Strategy
Amit K SachdevSenior VP:Global Government StrategyThomas ConnollySenior VP:Human Resources
Kelly LewisDirector:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil